(S)-Benzyl ((1-(2-chloroacetyl)pyrrolidin-2-yl)methyl)(isopropyl)carbamate

Catalog No. :
ACCKIE692
CAS No. :
1354008-73-3
Molecular Formula :
C18H25ClN2O3
Molecular Weight :
352.86

IUPAC Name:benzyl (S)-((1-(2-chloroacetyl)pyrrolidin-2-yl)methyl)(isopropyl)carbamate

(S)-Benzyl ((1-(2-chloroacetyl)pyrrolidin-2-yl)methyl)(isopropyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$1397.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-Benzyl ((1-(2-chloroacetyl)pyrrolidin-2-yl)methyl)(isopropyl)carbamate
IUPAC Namebenzyl (S)-((1-(2-chloroacetyl)pyrrolidin-2-yl)methyl)(isopropyl)carbamate
Molecular FormulaC18H25ClN2O3
Molecular Weight352.86
SMILESO=C(OCC1=CC=CC=C1)N(C[C@H]2N(C(CCl)=O)CCC2)C(C)C
InChI KeyLSKVKDCEKUBYPD-INIZCTEOSA-N
Synonym[(S)-1-(2-Chloro-acetyl)-pyrrolidin-2-ylmethyl]-isopropyl-carbamic acid benzyl ester;Carbamic acid, N-[[(2S)-1-(2-chloroacetyl)-2-pyrrolidinyl]methyl]-N-(1-methylethyl)-, phenylmethyl ester
CAS No.1354008-73-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACCKIE692 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCKIE692 route product structure diagram
    ACCKIE6921354008-73-3
Inquiry

2. ACCKIE692 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCKIE692 route product structure diagram
    ACCKIE6921354008-73-3
Inquiry

Comments (0)